SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Morgan Stanley Maintains Overweight on Viela Bio, Raises Price Target to $55

Morgan Stanley maintains Viela Bio (NASDAQ:VIE) with a Overweight and raises the price target from $54 to $55.

Benzinga · 05/14/2020 12:02

Morgan Stanley maintains Viela Bio (NASDAQ:VIE) with a Overweight and raises the price target from $54 to $55.